| Post |
| Pre |
| LA |
|---|
| 1 |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 1 | - | - | 4 | - | - | - | - | 7 |
| - | - | 0.5 | - | - | - | - | - | - | - | 0.5 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 36.8 | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 16.2 |
| 0.2 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 141.5 |
| 5 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| CentralBrain-unspecified | 277 | 26.0% | -4.21 | 15 | 62.5% |
| PLP(L) | 283 | 26.6% | -5.82 | 5 | 20.8% |
| Optic-unspecified(L) | 277 | 26.0% | -7.11 | 2 | 8.3% |
| LO(L) | 147 | 13.8% | -inf | 0 | 0.0% |
| AME(L) | 65 | 6.1% | -6.02 | 1 | 4.2% |
| ME(L) | 8 | 0.8% | -3.00 | 1 | 4.2% |
| SLP(L) | 6 | 0.6% | -inf | 0 | 0.0% |
| LA(L) | 1 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns Lat1 | % In | CV |
|---|---|---|---|---|---|
| MeVP38 (L) | 1 | ACh | 25 | 9.9% | 0.0 |
| MeVP14 (L) | 15 | ACh | 25 | 9.9% | 0.7 |
| 5thsLNv_LNd6 (L) | 2 | ACh | 18.5 | 7.3% | 0.1 |
| MeVPaMe2 (R) | 1 | Glu | 17.8 | 7.0% | 0.0 |
| MeVP11 (L) | 18 | ACh | 17.5 | 6.9% | 0.8 |
| aMe1 (L) | 2 | GABA | 16.8 | 6.6% | 0.2 |
| DNpe053 (L) | 1 | ACh | 11.2 | 4.5% | 0.0 |
| MeLo1 (L) | 20 | ACh | 11 | 4.4% | 0.7 |
| LoVP96 (L) | 1 | Glu | 10 | 4.0% | 0.0 |
| MeTu4c (L) | 11 | ACh | 5.2 | 2.1% | 0.5 |
| aMe2 (L) | 4 | Glu | 5 | 2.0% | 0.7 |
| SLP322 (L) | 4 | ACh | 4.8 | 1.9% | 0.6 |
| DNpe053 (R) | 1 | ACh | 3.5 | 1.4% | 0.0 |
| LT43 (L) | 2 | GABA | 3.2 | 1.3% | 0.5 |
| LC14b (R) | 4 | ACh | 3.2 | 1.3% | 0.5 |
| aMe5 (L) | 7 | ACh | 3 | 1.2% | 0.6 |
| MeVC20 (L) | 2 | Glu | 2.8 | 1.1% | 0.3 |
| MeVP1 (L) | 8 | ACh | 2.8 | 1.1% | 0.5 |
| MeLo3b (L) | 8 | ACh | 2.8 | 1.1% | 0.4 |
| MeVCMe1 (L) | 1 | ACh | 2.5 | 1.0% | 0.0 |
| MeTu4f (L) | 5 | ACh | 2.5 | 1.0% | 0.3 |
| MeLo6 (L) | 4 | ACh | 2.5 | 1.0% | 0.7 |
| MeTu4a (L) | 6 | ACh | 2.5 | 1.0% | 0.3 |
| MeVCMe1 (R) | 2 | ACh | 2.2 | 0.9% | 0.3 |
| MeVP15 (L) | 5 | ACh | 2.2 | 0.9% | 0.6 |
| aMe4 (L) | 3 | ACh | 2 | 0.8% | 0.6 |
| aMe6b (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| LoVP12 (L) | 4 | ACh | 2 | 0.8% | 0.4 |
| aMe3 (L) | 1 | Glu | 1.8 | 0.7% | 0.0 |
| TmY17 (L) | 4 | ACh | 1.8 | 0.7% | 0.2 |
| aMe30 (L) | 3 | Glu | 1.8 | 0.7% | 0.5 |
| PLP231 (L) | 2 | ACh | 1.2 | 0.5% | 0.6 |
| MeVP29 (L) | 1 | ACh | 1.2 | 0.5% | 0.0 |
| MeTu3b (L) | 2 | ACh | 1.2 | 0.5% | 0.6 |
| TmY10 (L) | 4 | ACh | 1.2 | 0.5% | 0.3 |
| LoVCLo3 (L) | 1 | OA | 1 | 0.4% | 0.0 |
| aMe13 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| MeVPMe12 (R) | 2 | ACh | 1 | 0.4% | 0.5 |
| aMe6a (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LoVP57 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 1 | 0.4% | 0.0 |
| HBeyelet (L) | 3 | HA | 1 | 0.4% | 0.4 |
| LNd_b (L) | 2 | ACh | 1 | 0.4% | 0.0 |
| aMe6c (L) | 2 | Glu | 1 | 0.4% | 0.5 |
| Tm26 (L) | 1 | ACh | 0.8 | 0.3% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 0.8 | 0.3% | 0.0 |
| aMe12 (L) | 2 | ACh | 0.8 | 0.3% | 0.3 |
| MeVPaMe1 (L) | 1 | ACh | 0.8 | 0.3% | 0.0 |
| PLP174 (L) | 2 | ACh | 0.8 | 0.3% | 0.3 |
| CL356 (L) | 2 | ACh | 0.8 | 0.3% | 0.3 |
| MeVC22 (L) | 2 | Glu | 0.8 | 0.3% | 0.3 |
| DN1a (L) | 2 | Glu | 0.8 | 0.3% | 0.3 |
| LoVP71 (L) | 2 | ACh | 0.8 | 0.3% | 0.3 |
| LHPV5i1 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| MeVP63 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| LC14a-2 (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| MeVPLo2 (L) | 2 | ACh | 0.5 | 0.2% | 0.0 |
| LoVP9 (L) | 2 | ACh | 0.5 | 0.2% | 0.0 |
| CB1984 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| Lat2 (L) | 2 | unc | 0.5 | 0.2% | 0.0 |
| aMe8 (L) | 1 | unc | 0.5 | 0.2% | 0.0 |
| aMe9 (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| LoVP42 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| LPT53 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| MeLo2 (L) | 2 | ACh | 0.5 | 0.2% | 0.0 |
| MeVP3 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| MeVP5 (L) | 2 | ACh | 0.5 | 0.2% | 0.0 |
| LoVC22 (R) | 1 | DA | 0.5 | 0.2% | 0.0 |
| DNp32 (L) | 1 | unc | 0.2 | 0.1% | 0.0 |
| aMe22 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| LoVP60 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| LoVP89 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVPMe5 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| SLP460 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| SLP304 (L) | 1 | unc | 0.2 | 0.1% | 0.0 |
| LT80 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| LoVP53 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| SLP358 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Tm20 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeTu4e (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Tm16 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| LO_unclear (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| LT70 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| MeVP39 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| LT85 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVC21 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| LoVC23 (R) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| MeVP36 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| DNc02 (R) | 1 | unc | 0.2 | 0.1% | 0.0 |
| LoVP41 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| PLP119 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Lat1 (L) | 1 | unc | 0.2 | 0.1% | 0.0 |
| LoVP23 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| 5-HTPMPV01 (R) | 1 | 5-HT | 0.2 | 0.1% | 0.0 |
| aMe_TBD1 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| OA-AL2i3 (L) | 1 | OA | 0.2 | 0.1% | 0.0 |
| LoVP6 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| LoVP29 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| Li14 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Cm11a (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| aMe12 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVP33 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| downstream partner | # | NT | conns Lat1 | % Out | CV |
|---|---|---|---|---|---|
| MeVC21 (L) | 1 | Glu | 0.5 | 5.0% | 0.0 |
| LC9 (L) | 2 | ACh | 0.5 | 5.0% | 0.0 |
| DNp27 (L) | 1 | ACh | 0.5 | 5.0% | 0.0 |
| aMe17c (L) | 2 | Glu | 0.5 | 5.0% | 0.0 |
| aMe8 (L) | 2 | unc | 0.5 | 5.0% | 0.0 |
| MeVP3 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| MeVPMe12 (R) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| LC10c-1 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| Lat1 (L) | 1 | unc | 0.2 | 2.5% | 0.0 |
| aMe2 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |
| MeVP33 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| LoVC21 (R) | 1 | GABA | 0.2 | 2.5% | 0.0 |
| MeVP38 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| MeVC22 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |
| MeVP46 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| PLP080 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |
| MeLo1 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| MeVP6 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |
| MeVP58 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |
| MeVP61 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |
| CL125 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |
| ATL041 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| MeVP34 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| MeVP50 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| LoVP103 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| aMe20 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| LT88 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |
| MeVP29 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| DNpe053 (L) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| LT43 (L) | 1 | GABA | 0.2 | 2.5% | 0.0 |
| aMe17a (L) | 1 | unc | 0.2 | 2.5% | 0.0 |
| aMe22 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |
| LC14a-1 (R) | 1 | ACh | 0.2 | 2.5% | 0.0 |
| LT51 (L) | 1 | Glu | 0.2 | 2.5% | 0.0 |